Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts

Liver Diseases

Free Subscription Articles published in Semin Liver Dis Retrieve available abstracts of 51 articles: HTML format

Single Articles

April 2025
1. JIAO H, Wang H, Li J, Yang Z, et al
   The Molecular Pathogenesis of Sarcopenia/Frailty in Cirrhosis.
   Semin Liver Dis. 2025 Apr 16. doi: 10.1055/a-2564-7551.
   PubMed     Abstract available
   
   
   
2. RAMIREZ-QUESADA W, Alvarado-Tapias E, Shalaby S, Hernandez-Gea V, et al
   Recompensation in Cirrhosis: Biomarkers and Strategies.
   Semin Liver Dis. 2025 Apr 3. doi: 10.1055/a-2542-9930.
   PubMed     Abstract available
   
   
   
3. SONG Y, Yang X, Yu C
   Understanding and Treating Hepatorenal Syndrome: Insights from Recent Research.
   Semin Liver Dis. 2025 Apr 1. doi: 10.1055/a-2570-3330.
   PubMed     Abstract available
   
   
   March 2025
4. PANT K, Peixoto E, Gradilone SA
   Primary Cilia in Hepatic Biliary Hyperplasia: Implications for Liver Diseases.
   Semin Liver Dis. 2025 Mar 21. doi: 10.1055/a-2563-9791.
   PubMed     Abstract available
   
   
   
5. SEREROLS-VINAS L, Garcia-Vicien G, Ruiz-Blazquez P, Lee T, et al
   Hepatic stellate cells functional heterogeneity in liver cancer.
   Semin Liver Dis. 2025 Mar 5. doi: 10.1055/a-2551-0724.
   PubMed     Abstract available
   
   
   January 2025
6. PREMKUMAR M, Kajal K, Gupta P, Reddy R, et al
   Current Concepts in Fluid Resuscitation and Vasopressor Use in Cirrhosis.
   Semin Liver Dis. 2025 Jan 14. doi: 10.1055/a-2515-2783.
   PubMed     Abstract available
   
   
   November 2024
7. HUDSON D, Valentin Cortez FJ, Hurtado Diaz de Leon I, Malhi G, et al
   Advancements in MELD score and its impact in Hepatology.
   Semin Liver Dis. 2024 Nov 8. doi: 10.1055/a-2464-9543.
   PubMed     Abstract available
   
   
   
8. PRADO LG, Nagy LE
   Role of Complement in Liver Diseases.
   Semin Liver Dis. 2024;44:510-522.
   PubMed     Abstract available
   
   
   
9. POMPILI E, Iannone G, Carrello D, Zaccherini G, et al
   Managing Multiorgan Failure in Acute on Chronic Liver Failure.
   Semin Liver Dis. 2024;44:492-509.
   PubMed     Abstract available
   
   
   
10. SETHI N, Khokhar M, Mathur M, Batra Y, et al
    Therapeutic Potential of Nutraceuticals against Drug-Induced Liver Injury.
    Semin Liver Dis. 2024;44:430-456.
    PubMed     Abstract available
    
    
    
11. MAHER S, Rajapakse J, El-Omar E, Zekry A, et al
    Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Semin Liver Dis. 2024;44:457-473.
    PubMed     Abstract available
    
    
    
12. DE JONG YP
    Mice Engrafted with Human Liver Cells.
    Semin Liver Dis. 2024;44:405-415.
    PubMed     Abstract available
    
    
    October 2024
13. MEENA BL, Sarin SK
    Management of Portal vein Thrombosis in Cirrhosis.
    Semin Liver Dis. 2024 Oct 4. doi: 10.1055/s-0044-1791247.
    PubMed     Abstract available
    
    
    August 2024
14. ARTEEL GE
    Extracellular matrix and hepatic wound healing before fibrosis.
    Semin Liver Dis. 2024 Aug 27. doi: 10.1055/a-2404-7973.
    PubMed     Abstract available
    
    
    
15. BALLESTER MP, Durmazer EN, Qi T, Jalan R, et al
    The value of ammonia as a biomarker in patients with cirrhosis.
    Semin Liver Dis. 2024 Aug 2. doi: 10.1055/a-2378-8942.
    PubMed     Abstract available
    
    
    
16. ZHANG IW, Lurje I, Lurje G, Knosalla C, et al
    Combined Organ Transplantation in Patients with Advanced Liver Disease.
    Semin Liver Dis. 2024;44:369-382.
    PubMed     Abstract available
    
    
    
17. CHOI YJ, Kim Y, Hwang S
    Role of Neutrophils in the Development of Steatotic Liver Disease.
    Semin Liver Dis. 2024;44:300-318.
    PubMed     Abstract available
    
    
    
18. THAKRAL N, Desalegn H, Diaz LA, Cabrera D, et al
    A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD.
    Semin Liver Dis. 2024;44:273-286.
    PubMed     Abstract available
    
    
    
19. CHEN C, Feng D, Wang Y, Yao T, et al
    Necrotic Liver Lesion Resolution: Another Mode of Liver Regeneration.
    Semin Liver Dis. 2024;44:333-342.
    PubMed     Abstract available
    
    
    
20. KOTULKAR M, Paine-Cabrera D, Apte U
    Role of Hepatocyte Nuclear Factor 4 Alpha in Liver Cancer.
    Semin Liver Dis. 2024;44:383-393.
    PubMed     Abstract available
    
    
    
21. QIAN S, Wang X, Chen Y, Zai Q, et al
    Inflammation in Steatotic Liver Diseases: Pathogenesis and Therapeutic Targets.
    Semin Liver Dis. 2024;44:319-332.
    PubMed     Abstract available
    
    
    July 2024
22. TINCOPA MA, Loomba R
    Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic-Dysfunction-Associated Steatohepatitis.
    Semin Liver Dis. 2024 Jul 9. doi: 10.1055/s-0044-1788277.
    PubMed     Abstract available
    
    
    May 2024
23. BALOGUN O, Nejak-Bowen K
    Understanding Hepatic Porphyrias: Symptoms, Treatments, and Unmet Needs.
    Semin Liver Dis. 2024 May 17. doi: 10.1055/s-0044-1787076.
    PubMed     Abstract available
    
    
    
24. MA J, Bjornsson ES, Chalasani N
    Hepatotoxicity of Antibiotics and Antifungals and Their Safe Use in Hepatic Impairment.
    Semin Liver Dis. 2024 May 13. doi: 10.1055/s-0044-1787062.
    PubMed     Abstract available
    
    
    
25. WERNER W, Kuzminskaya M, Lurje I, Tacke F, et al
    Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?
    Semin Liver Dis. 2024;44:159-179.
    PubMed     Abstract available
    
    
    
26. FISCHER AM, Lechea N, Coxson HO
    This Is What Metabolic Dysfunction-Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol.
    Semin Liver Dis. 2024;44:226-238.
    PubMed     Abstract available
    
    
    
27. LI CC, Liu M, Lee HP, Wu W, et al
    Heterogeneity in Liver Cancer Immune Microenvironment: Emerging Single-Cell and Spatial Perspectives.
    Semin Liver Dis. 2024;44:133-146.
    PubMed     Abstract available
    
    
    
28. PHAM N, Benhammou JN
    Statins in Chronic Liver Disease: Review of the Literature and Future Role.
    Semin Liver Dis. 2024;44:191-208.
    PubMed     Abstract available
    
    
    
29. FUJIWARA N, Kimura G, Nakagawa H
    Emerging Roles of Spatial Transcriptomics in Liver Research.
    Semin Liver Dis. 2024;44:115-132.
    PubMed     Abstract available
    
    
    April 2024
30. SAVIANO A, Roehlen N, Baumert TF
    Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma.
    Semin Liver Dis. 2024 Apr 22. doi: 10.1055/s-0044-1785646.
    PubMed     Abstract available
    
    
    March 2024
31. KODAMA T, Takehara T
    Molecular genealogy of metabolic-associated hepatocellular carcinoma.
    Semin Liver Dis. 2024 Mar 18. doi: 10.1055/a-2289-2298.
    PubMed     Abstract available
    
    
    February 2024
32. ROMERO-GOMEZ M, Arab JP, Oliveira CP, Hernandez M, et al
    Is There a Safe Alcohol Consumption Limit for the General Population and in Patients with Liver Disease?
    Semin Liver Dis. 2024;44:69-78.
    PubMed     Abstract available
    
    
    
33. CANIVET CM, Boursier J, Loomba R
    New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice.
    Semin Liver Dis. 2024;44:35-42.
    PubMed     Abstract available
    
    
    
34. MOUZAKI M, Woo JG, Divanovic S
    Gestational and Developmental Contributors of Pediatric MASLD.
    Semin Liver Dis. 2024;44:43-53.
    PubMed     Abstract available
    
    
    
35. TUTUSAUS A, Morales A, Garcia de Frutos P, Mari M, et al
    GAS6/TAM Axis as Therapeutic Target in Liver Diseases.
    Semin Liver Dis. 2024;44:99-114.
    PubMed     Abstract available
    
    
    
36. BESSONE F, Hillotte GL, Ahumada N, Jaureguizahar F, et al
    UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological Basis.
    Semin Liver Dis. 2024;44:1-22.
    PubMed     Abstract available
    
    
    
37. EL-KASSAS M, Awad A, Elbadry M, Arab JP, et al
    Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Semin Liver Dis. 2024;44:54-68.
    PubMed     Abstract available
    
    
    
38. BECH KT, Lindvig KP, Thiele M, Castera L, et al
    Algorithms for Early Detection of Silent Liver Fibrosis in the Primary Care Setting.
    Semin Liver Dis. 2024;44:23-34.
    PubMed     Abstract available
    
    
    
39. LIU H, Sethi V, Li X, Xiao Y, et al
    Corrigendum: Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future.
    Semin Liver Dis. 2024;44:e1-e3.
    PubMed    
    
    
    January 2024
40. LIU H, Sethi V, Li X, Xiao Y, et al
    Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future.
    Semin Liver Dis. 2024 Jan 11. doi: 10.1055/a-2242-7543.
    PubMed     Abstract available
    
    
    November 2023
41. BALOGUN O, Nejak-Bowen K
    The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease.
    Semin Liver Dis. 2023 Nov 16. doi: 10.1055/s-0043-1776760.
    PubMed     Abstract available
    
    
    
42. WILSON SR, Duncan AW
    The Ploidy State as a Determinant of Hepatocyte Proliferation.
    Semin Liver Dis. 2023 Nov 15. doi: 10.1055/a-2211-2144.
    PubMed     Abstract available
    
    
    
43. HAN X, Sun Q, Xu M, Zhu G, et al
    Unraveling the Complexities of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.
    Semin Liver Dis. 2023 Nov 6. doi: 10.1055/s-0043-1776127.
    PubMed     Abstract available
    
    
    
44. SAEIDINEJAD M, Elshabrawi A, Sriphoosanaphan S, Andreola F, et al
    Novel Therapeutic Approaches in Treatment of Acute-on-Chronic Liver Failure.
    Semin Liver Dis. 2023;43:429-445.
    PubMed     Abstract available
    
    
    
45. DUTTA RK, Jun J, Du K, Diehl AM, et al
    Hedgehog Signaling: Implications in Liver Pathophysiology.
    Semin Liver Dis. 2023;43:418-428.
    PubMed     Abstract available
    
    
    August 2023
46. PEKARSKA K, Parker R
    Alcohol-Related Liver Disease: Is There a Safe Alcohol Consumption Limit for Liver Disease?
    Semin Liver Dis. 2023;43:305-310.
    PubMed     Abstract available
    
    
    
47. RANJBARIAN T, Schnabl B
    Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease.
    Semin Liver Dis. 2023;43:311-322.
    PubMed     Abstract available
    
    
    
48. DESHMUKH K, Apte U
    The Role of Endoplasmic Reticulum Stress Response in Liver Regeneration.
    Semin Liver Dis. 2023;43:279-292.
    PubMed     Abstract available
    
    
    
49. MEADOWS V, Yang Z, Basaly V, Guo GL, et al
    FXR Friend-ChIPs in the Enterohepatic System.
    Semin Liver Dis. 2023;43:267-278.
    PubMed     Abstract available
    
    
    
50. COOPER SA, Kostallari E, Shah VH
    Angiocrine Signaling in Sinusoidal Health and Disease.
    Semin Liver Dis. 2023;43:245-257.
    PubMed     Abstract available
    
    
    
51. RUIZ M, Lacaille F, Schrader C, Pons M, et al
    Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency.
    Semin Liver Dis. 2023;43:258-266.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.